Skip to content
Screener

Reported August 12, 2025 · Before market open

EPS-$0.07Miss by $0.01
EPS estimate-$0.06

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.92

FAQ

When did Atossa Therapeutics, Inc. report Q2 2025 earnings?
Atossa Therapeutics, Inc. (ATOS) reported Q2 2025 earnings on August 12, 2025 before market open.
What were Atossa Therapeutics, Inc.'s Q2 2025 revenue and EPS?
Atossa Therapeutics, Inc. reported eps of $-0.07 for Q2 2025.
Did Atossa Therapeutics, Inc. beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.06 by $0.01.
How did Atossa Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 40.0% from $-0.05.
Where can I find Atossa Therapeutics, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-106944) and the 10-Q periodic report (0000950170-25-106947) directly on SEC EDGAR. The filing index links above go to sec.gov.